Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tumor Boards
Colleague Insights
Living Resources
Conferences
Video Expert Opinion
Round Table Discussions
Sign in
Join now
Oliver Sartor MD
Oliver Sartor MD Advisory Board
Barbara Burtness MD
Barbara Burtness MD Advisory Board
Guru Sonpavde MD
Guru P. Sonpavde MD Advisory Board
See All Experts
featured
Published in Oncology and
1 other channel

Expert Opinion / Interview · August 01, 2016

Role of Biomarkers in Therapy Selection for Upfront Hormone-Sensitive Prostate Cancer

Farzanna Haffizulla MD, FACP, FAMWA
Gautam Jha MD
Interview with
Gautam Jha MD
Guru Sonpavde MD
Interview with
Guru P. Sonpavde MD
Jonathan Silberstein MD, MBA
Tanya Dorff MD
Interview with
Tanya B Dorff MD

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Guru Sonpavde MD

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.

Further Reading

Most Watched This Week

Related Videos